WA5-27926-59528
2 vaccinations
4 coded responses
19 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 801 / CO
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Registered in v-safe
-
2021-01-15
Dose 1 — Pfizer-BioNTech
- 2021-01-15
-
2021-01-16
Survey response — days 1–6 daily, dose 1MedDRA: Chills, Hyperaesthesia — Feeling: Good · Site: Pain · ChillsFree text: Chills as in sensitivity to the skin for ~12hrs after the vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-17
- 2021-01-18
- 2021-01-21
-
2021-01-29
Survey response — day 14, dose 1MedDRA: Diarrhoea, Vomiting — Feeling: FairFree text: Diarrhea and vomiting (2 mornings in the early morning)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Dose 2 — Pfizer-BioNTech
- 2021-02-04
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Pain, Pain in extremity — Feeling: Fair · Site: Pain, Swelling · Muscle or body achesFree text: Dull pain in arm radiating from site of injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-06
- 2021-03-11
- 2021-05-06
- 2021-08-05
-
2022-02-04
Survey response — 12 months, dose 2MedDRA: Caesarean section, Post procedural pulmonary embolism — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Provoked Pulmonary embolism after c-sectionMedDRA releases: 2024-11 · check-in free text available
-
2022-02-04
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-02-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Pfizer-BioNTech | |
| 2 | 2021-02-04 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-04 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Chills as in sensitivity to the skin for ~12hrs after the vaccine
Release 3 — day 14, dose 1
Symptoms: Diarrhea and vomiting (2 mornings in the early morning)
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Dull pain in arm radiating from site of injection
Release 11 — 12 months, dose 2
Symptoms: Provoked Pulmonary embolism after c-section
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Caesarean section | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Post procedural pulmonary embolism | · | · | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Hyperaesthesia | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release